Santhera Appoints Marc Clausse as Chief Commercial Officer to Lead Next Phase of Growth...
Pratteln, Switzerland, March 10, 2026 Santhera Pharmaceuticals (SIX: SANN) announces the appointment of Marc Clausse as Chief Commercial Officer (CCO), effective June 1, 2026. He succeeds Geert Jan … [+5659 chars]









